Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Bon Natural Life Limited (BON)

1.1100 +0.0001 (+0.01%)
At close: November 10 at 4:00:01 PM EST
Chart Range Bar
Loading chart for BON
Chart does not reflect overnight price.
  • Previous Close 1.1099
  • Open 1.1200
  • Bid 0.8424 x 200
  • Ask 1.3600 x 200
  • Day's Range 1.1100 - 1.1200
  • 52 Week Range 0.9500 - 2.0000
  • Volume 1,410
  • Avg. Volume 8,821
  • Market Cap (intraday) 9.067M
  • Beta (5Y Monthly) -0.25
  • PE Ratio (TTM) --
  • EPS (TTM) -2.7900
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors. The company serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.

www.bnlus.com

96

Full Time Employees

September 30

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/10/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BON
30.19%
S&P 500 (^GSPC)
9.87%

1-Year Return

BON
44.50%
S&P 500 (^GSPC)
10.08%

3-Year Return

BON
98.94%
S&P 500 (^GSPC)
70.34%

5-Year Return

BON
99.93%
S&P 500 (^GSPC)
61.85%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -60.39%

  • Return on Assets (ttm)

    -7.05%

  • Return on Equity (ttm)

    -21.76%

  • Revenue (ttm)

    18.82M

  • Net Income Avi to Common (ttm)

    -11.37M

  • Diluted EPS (ttm)

    -2.7900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.78M

  • Total Debt/Equity (mrq)

    25.65%

  • Levered Free Cash Flow (ttm)

    -20.12M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: